Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 201-377-6 | CAS number: 81-81-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Repeated dose toxicity: oral
Administrative data
- Endpoint:
- short-term repeated dose toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Reliability:
- 3 (not reliable)
- Rationale for reliability incl. deficiencies:
- other: No guideline mentioned, no test substance information
Data source
Reference
- Reference Type:
- publication
- Title:
- Toxic Effects of Warfarin in Rats fed Different Diets
- Author:
- Colvin HW, Wang WL
- Year:
- 1 974
- Bibliographic source:
- Toxicology and Applied Pharmacology, 28:pp 337-348
Materials and methods
Test guideline
- Qualifier:
- no guideline followed
- GLP compliance:
- not specified
Test material
- Reference substance name:
- Warfarin
- EC Number:
- 201-377-6
- EC Name:
- Warfarin
- Cas Number:
- 81-81-2
- Molecular formula:
- C19H16O4
- IUPAC Name:
- 4-hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one
- Details on test material:
- No data
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- Male Sprague-Dawley rats were used weighing 250-300 g. They were individually caged in a room at 22 degrees C. Two groups were given different
diets. One was Purina Chow ( 23.4% protein, 3.78% fat, 50.58% nitrogen-free extract, 4.86% fiber). The other group was given oat groats ( 12.0%
protein, 6.0% fat, 65.5% nitrogen free extract, 2.0% fiber).
Administration / exposure
- Route of administration:
- other: Oral feeding needle
- Vehicle:
- other: 0.1 N NAOH
- Details on oral exposure:
- A 7 day dietary adjustment period preceeded the Warfarin administration. The Warfarin was administered at a dose of 0.8 mg/kg with a rat
oral feeding needle five hours after fasting - Analytical verification of doses or concentrations:
- not specified
- Duration of treatment / exposure:
- Five days
- Frequency of treatment:
- Once every 24 hours
Doses / concentrations
- Remarks:
- Doses / Concentrations:
0.8 mg/ kg
Basis:
other: Rat oral feeding needle
- No. of animals per sex per dose:
- 30 male rats per dose group
- Control animals:
- yes, concurrent no treatment
- Details on study design:
- The lethal dose of warfarin was reported to be 1 mg/kg. When this dose was administered for 5 days, it was found to be excessive. It was found that
most rats would survive the 5 day period if force fed 0.8 mg/kg/day.
Examinations
- Sacrifice and pathology:
- Five rats from each group were sacrificed at 0, 5, 29, 53, 77 and 101 hours after the initial warfarin administration. Once anesthetized, the thorax was
opened and blood samples drawn from the still beating heart and heparinized and used for the determination of total plasma protein, hematocrit and plasma protein fractionation. For the second sample, the blood was diluted with 0.1 m sodium citrate in 0.9% NaCl solution. The citrated blood
was centrifuged immediately and the plasma was used for the determination of warfarin, prothrombin time and fibrinogen. - Other examinations:
- The livers were excised, weighed and frozen and used to determine warfarin concentrations.
- Statistics:
- All statistical techniques that were used , were considered in Steel and Torrie (1960).
Results and discussion
Results of examinations
- Details on results:
- The Plasma warfarin concentration increased more rapidly in the oat-fed rats. However, in the liver warfarin:plasma warfarin ratio following the first dose of warfarin indicated that the chow fed rats were removing the warfarin from the plasma more rapidly. There was less liver damage in the chow-fed rats because they had lower plasma fibrinogen concentrations then the oat-fed group. The linear decline in total plasma protein in each group was a function of linear declines in plasma albumin and globulin.
Effect levels
- Dose descriptor:
- dose level:
- Effect level:
- 0.8 mg/kg bw/day (nominal)
- Sex:
- male
Target system / organ toxicity
- Critical effects observed:
- not specified
Applicant's summary and conclusion
- Conclusions:
- It was concluded that the repeat doses of warfarin was influenced by protein in the diet. Rats fed higher protein diets were more tolerate to warfarin.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
